Is Illumina Inc (ILMN) overvalued? · rev $4.34B
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
This page asks whether Illumina Inc (ILMN) looks expensive on cached numbers — not a short thesis.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
ILMN currently screens at market cap $15.84B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ILMN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ILMN stock page for the full model, not this heading.
Not investment advice.